GLP-1 Receptor Agonist Evidence: Risks and Expert Guidance
GLP-1 receptor agonist dosing safety is critical for effective therapy and minimizing risks. This article reviews evidence and expert guidance on dosing strategies. Understanding dosing safety helps clinicians optimize patient outcomes with GLP-1…
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Neuropathic pain cannabis treatment shows promise but remains inconclusive due to study limitations. Trials reveal mixed evidence with no definitive winners yet. Careful dosing and further research are essential for clinical guidance.
Week in Weed – April 25, 2026 – StratCann Insights
This article provides weekly cannabis clinical updates April 25 2026 from StratCann. It highlights emerging regulatory news and clinical relevance impacting patient care. Clinicians should review these updates to stay informed on industry developments.
Medicinal Cannabis Matters: Friday Roundup – 24 April 2026 – Medicann
This roundup highlights key medicinal cannabis clinical updates from April 2026. It covers emerging regulatory news and research findings relevant to medical cannabis practice. Healthcare professionals should monitor these updates for informed patient…
#ICYMI Our Zoe Mowery Explored a Pioneering Virginia Tech Cannabis Study
This article reviews the Virginia Tech cannabis study emphasizing clinical relevance. It highlights the need for peer-reviewed cannabis research in clinical practice. Social media summaries require verification before informing patient care decisions.
Cannabis-based interventions might help a little with neuropathic pain – Study Summary
Cannabis neuropathic pain relief shows modest improvements in patients with challenging neuropathic pain. Studies reveal small to moderate benefits from cannabis-based interventions. This evidence supports cautious use as adjunct therapy for neuropathic…
Major Review Finds Very Little Evidence for Cannabis Treating Anxiety, PTSD, or Psychotic Disorders
A major cannabis efficacy anxiety PTSD review reveals very little evidence supporting cannabis use for anxiety and PTSD. This challenges common clinical assumptions and highlights the need for more rigorous research. Patients and clinicians should…
Medicinal Cannabis Matters: Friday Roundup – 27 March 2026 | Medicann
This Friday roundup highlights important medicinal cannabis clinical updates 2026. It summarizes emerging findings and policy developments in cannabis medicine. Stay current with weekly cannabis medicine news and evidence reviews.
Local Therapeutic Strategies for Neurocutaneous Dysesthesia: From Capsaicin to Cannabinoids
Local therapeutic strategies neurocutaneous dysesthesia focus on topical treatments such as capsaicin and cannabinoids to manage abnormal skin sensations. These approaches provide targeted relief with fewer systemic effects. This review highlights…
Student Spotlight: DaSeul An | Johns Hopkins | Bloomberg School of Public Health
This student cannabis research spotlight highlights DaSeul An's work at Johns Hopkins Bloomberg School of Public Health. The research contributes to emerging cannabis public health knowledge. Student cannabis research spotlights signal new directions in…
